Eris Lifesciences Limited (NSE:ERIS) — Stock Price

Rs1393.40 INR
▲ 0.80% today

Eris Lifesciences Limited (NSE:ERIS) is currently trading at Rs1393.40 INR, up 0.80% today. Over the past 52 weeks, shares have ranged between Rs1271.00 and Rs1801.70. This page tracks Eris Lifesciences Limited's live share price on the NSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see ERIS market cap overview.

Eris Lifesciences Limited (ERIS) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Eris Lifesciences Limited's daily closing share price and trading volume on the NSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

Eris Lifesciences Limited Income Statement — Revenue, Profit & Earnings by Year

Eris Lifesciences Limited's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue Rs28.79 Billion Rs19.91 Billion Rs16.62 Billion Rs13.26 Billion Rs11.93 Billion
Cost of Revenue Rs7.30 Billion Rs9.97 Billion Rs3.52 Billion Rs2.61 Billion Rs2.42 Billion
Gross Profit Rs21.49 Billion Rs9.95 Billion Rs13.09 Billion Rs10.65 Billion Rs9.51 Billion
Research & Development Rs24.40 Million Rs57.18 Million Rs61.00 Million Rs327.38 Million Rs50.92 Million
SG&A Rs5.08 Billion Rs714.79 Million Rs471.75 Million Rs504.09 Million Rs430.35 Million
Total Operating Expenses Rs5.27 Billion Rs4.94 Billion Rs3.61 Billion Rs6.40 Billion Rs5.62 Billion
Operating Income Rs16.60 Billion Rs4.95 Billion Rs4.29 Billion Rs4.31 Billion Rs3.96 Billion
EBITDA Rs10.17 Billion Rs6.99 Billion Rs5.48 Billion Rs5.11 Billion Rs4.39 Billion
EBIT Rs7.02 Billion Rs5.16 Billion Rs4.31 Billion Rs4.46 Billion Rs3.96 Billion
Interest Expense Rs2.31 Billion Rs848.01 Million Rs261.68 Million Rs42.19 Million Rs19.75 Million
Income Before Tax Rs4.89 Billion Rs4.31 Billion Rs4.05 Billion Rs4.42 Billion Rs3.94 Billion
Income Tax Expense Rs1.14 Billion Rs341.85 Million Rs304.83 Million Rs364.09 Million Rs393.62 Million
Net Income Rs3.52 Billion Rs3.92 Billion Rs3.82 Billion Rs4.06 Billion Rs3.55 Billion

Eris Lifesciences Limited Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Eris Lifesciences Limited's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets Rs70.33 Billion Rs70.49 Billion Rs36.67 Billion Rs22.72 Billion Rs18.35 Billion
Total Current Assets Rs12.23 Billion Rs23.02 Billion Rs7.65 Billion Rs6.27 Billion Rs4.67 Billion
Cash & Equivalents — — — — —
Short-term Investments Rs50.00 Million Rs12.45 Billion Rs332.21 Million Rs1.63 Billion Rs153.99 Million
Net Receivables Rs4.59 Billion Rs4.22 Billion Rs2.93 Billion Rs2.09 Billion Rs1.47 Billion
Inventory Rs3.35 Billion Rs1.89 Billion Rs1.31 Billion Rs1.18 Billion Rs944.66 Million
Property, Plant & Equipment Rs7.29 Billion Rs5.58 Billion Rs3.77 Billion Rs1.92 Billion Rs778.78 Million
Goodwill Rs9.12 Billion Rs8.61 Billion Rs3.32 Billion Rs934.74 Million Rs934.74 Million
Total Liabilities Rs37.61 Billion Rs38.27 Billion Rs14.47 Billion Rs3.64 Billion Rs2.58 Billion
Total Current Liabilities Rs13.81 Billion Rs25.32 Billion Rs4.43 Billion Rs2.00 Billion Rs1.67 Billion
Long-term Debt Rs17.38 Billion Rs6.55 Billion Rs6.44 Billion Rs450.00 Million Rs0.00
Net Debt Rs22.55 Billion Rs26.87 Billion Rs8.21 Billion Rs336.13 Million Rs-300.93 Million
Total Stockholder Equity Rs28.54 Billion Rs25.86 Billion Rs21.96 Billion Rs19.08 Billion Rs15.76 Billion
Retained Earnings Rs27.93 Billion Rs25.41 Billion Rs21.56 Billion Rs18.74 Billion Rs15.50 Billion

Eris Lifesciences Limited Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Eris Lifesciences Limited generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow Rs10.65 Billion Rs4.86 Billion Rs2.92 Billion Rs3.78 Billion Rs3.75 Billion
Capital Expenditures Rs1.55 Billion Rs1.29 Billion Rs8.41 Billion Rs1.21 Billion Rs257.63 Million
Free Cash Flow Rs9.10 Billion Rs3.57 Billion Rs-5.50 Billion Rs2.57 Billion Rs3.50 Billion
Investing Cash Flow Rs-799.70 Million Rs-18.55 Billion Rs-9.82 Billion Rs-3.20 Billion Rs-3.23 Billion
Financing Cash Flow Rs-8.81 Billion Rs13.80 Billion Rs6.88 Billion Rs-446.99 Million Rs-823.95 Million
Dividends Paid Rs-1.00 Billion Rs0.00 Rs999.11 Million Rs816.23 Million Rs746.79 Million
Stock-Based Compensation Rs91.30 Million Rs7.50 Million Rs31.21 Million Rs13.55 Million Rs11.20 Million
Depreciation Rs3.15 Billion Rs1.83 Billion Rs1.17 Billion Rs647.05 Million Rs429.85 Million
Change in Cash Rs1.05 Billion Rs382.23 Million Rs51.52 Million Rs139.55 Million Rs-303.92 Million

Eris Lifesciences Limited Earnings History — EPS Actual vs. Analyst Estimates

Track Eris Lifesciences Limited's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
May 18, 2026 — — —
Feb 13, 2026 8.26 9.05 -8.73%
Nov 12, 2025 8.81 9.20 -4.24%
Aug 05, 2025 8.64 8.73 -1.03%
May 19, 2025 6.89 7.10 -2.96%
Feb 04, 2025 6.14 6.57 -6.54%
Oct 25, 2024 6.72 7.20 -6.67%
Aug 02, 2024 6.10 6.30 -3.17%